Nobel Laureate Jennifer Doudna discusses the groundbreaking development of CRISPR gene editing technology and its transformative impact on biomedicine. As a leading scientist at UC Berkeley, she reflects on the scientific journey that led to this innovation and highlights current advancements in precision genetic modification. The conversation explores how CRISPR could one day offer cures for inherited disorders and complex diseases, emphasizing the importance of responsible research and ethical oversight. Doudna also critiques the limited understanding many tech industry leaders have about biological systems, stressing the need for deeper collaboration between disciplines.
The discussion turns to the limitations of artificial intelligence in solving major health challenges, noting that biological complexity cannot be addressed through digital tools alone. Doudna calls for structural reforms in how science is funded and integrated with technological development, advocating for stronger bridges between computational innovation and real-world biology. She underscores the urgency of aligning scientific progress with societal needs, ensuring that breakthroughs like CRISPR are applied safely and equitably. This episode offers a critical view of where bio-innovation stands and what it will take to realize its full potential.